Prostate Cancer

As the frequency of late-stage cancer diagnoses rises, more accurate and efficient screening methods are needed to address overspending and improve early detection outcomes

PROSTOX ultra is the first and only molecular diagnostic test to use biology and genetics to predict radiation toxicity

The test could enable at-home testing and increased access to testing for patients undergoing telehealth care or living in remote areas

A third of Phase 2 clinical trials were terminated in 2024, a 50 percent increase from before the pandemic

New resource from the National Comprehensive Cancer Network outlines how and why to access genetic counseling and testing for multiple hereditary cancers

Prostate cancer is a leading cause of cancer deaths in American men

ISS National Lab helps fuel the development of groundbreaking treatment for all types of cancer and beyond

AI-identified biomarker-based test reduces need for prostate biopsies in men with high PSA levels

Factor previously known to play a role in advanced cancer is fundamental in early stages of cancer development

Study finds PSA tests may give false reassurance for transgender women on estrogen therapy and could miss some cancers